tiprankstipranks
Roche’s mixed myasthenia gravis data sending these stocks in opposite directions
PremiumThe FlyRoche’s mixed myasthenia gravis data sending these stocks in opposite directions
1M ago
Tourmaline Bio might see weakness today after Roche MG data, says Truist
PremiumThe Fly
Tourmaline Bio might see weakness today after Roche MG data, says Truist
1M ago
Immunovant rallies after Chugai myasthenia gravis study failure
PremiumThe Fly
Immunovant rallies after Chugai myasthenia gravis study failure
1M ago
Wolfe starts Immunovant at Outperform, says excited about catalyst path
PremiumThe FlyWolfe starts Immunovant at Outperform, says excited about catalyst path
2M ago
Immunovant initiated with an Outperform at Wolfe Research
PremiumThe Fly
Immunovant initiated with an Outperform at Wolfe Research
2M ago
Immunovant remains top pick at Citi after year-to-date selloff
PremiumThe Fly
Immunovant remains top pick at Citi after year-to-date selloff
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100